BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16195247)

  • 1. The evolution of mineralocorticoid receptors.
    Hu X; Funder JW
    Mol Endocrinol; 2006 Jul; 20(7):1471-8. PubMed ID: 16195247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of hormone selectivity in glucocorticoid and mineralocorticoid receptors.
    Baker ME; Funder JW; Kattoula SR
    J Steroid Biochem Mol Biol; 2013 Sep; 137():57-70. PubMed ID: 23907018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptors: evolutionary and pathophysiological considerations.
    Kassahn KS; Ragan MA; Funder JW
    Endocrinology; 2011 May; 152(5):1883-90. PubMed ID: 21343255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Pro-637 and Gln-642 in human glucocorticoid receptors and Ser-843 and Leu-848 in mineralocorticoid receptors in their differential responses to cortisol and aldosterone.
    Mani O; Nashev LG; Livelo C; Baker ME; Odermatt A
    J Steroid Biochem Mol Biol; 2016 May; 159():31-40. PubMed ID: 26907965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of the recognition of ulipristal acetate by oxo-steroid receptors.
    Petit-Topin I; Fay M; Resche-Rigon M; Ulmann A; Gainer E; Rafestin-Oblin ME; Fagart J
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():427-35. PubMed ID: 25204619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and evolutionary analysis of the co-activator binding domain in vertebrate progesterone receptors.
    Kattoula SR; Baker ME
    J Steroid Biochem Mol Biol; 2014 May; 141():7-15. PubMed ID: 24388949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological effect of halogen substituted phenyl acetic acid derivatives of progesterone as potent progesterone receptor antagonists.
    Cabeza M; Bratoeff E; Gómez G; Heuze I; Rojas A; Ochoa M; Palomino MA; Revilla C
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):232-9. PubMed ID: 18625316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modelling of the ligand binding domain of mineralocorticoid receptor: close structural kinship with glucocorticoid receptor ligand binding domain and their similar binding mode with DOC (de-oxy corticosterone).
    Dey R; Roychowdhury P
    J Biomol Struct Dyn; 2002 Aug; 20(1):21-9. PubMed ID: 12144349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal domain regulates steroid activation of elephant shark glucocorticoid and mineralocorticoid receptors.
    Katsu Y; Shariful IMD; Lin X; Takagi W; Urushitani H; Kohno S; Hyodo S; Baker ME
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105845. PubMed ID: 33652098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells--toward a basis for the opposite actions elicited by two nuclear receptors?
    Obradović D; Tirard M; Némethy Z; Hirsch O; Gronemeyer H; Almeida OF
    Mol Pharmacol; 2004 Mar; 65(3):761-9. PubMed ID: 14978255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational research goes both ways: lessons from clinical studies.
    Funder JW
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):526-9. PubMed ID: 18307755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
    Li Y; Suino K; Daugherty J; Xu HE
    Mol Cell; 2005 Aug; 19(3):367-80. PubMed ID: 16061183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptor profiling of vinclozolin and its primary metabolites.
    Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Evolution of the mineralocorticoid receptor: sequence, structure and function.
    Baker ME; Katsu Y
    J Endocrinol; 2017 Jul; 234(1):T1-T16. PubMed ID: 28468932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
    Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
    Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning and characterization of the corticoid receptors from the American alligator.
    Oka K; Kohno S; Urushitani H; Guillette LJ; Ohta Y; Iguchi T; Katsu Y
    Mol Cell Endocrinol; 2013 Jan; 365(2):153-61. PubMed ID: 23127802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the Mineralocorticoid Receptor.
    Baker ME; Katsu Y
    Vitam Horm; 2019; 109():17-36. PubMed ID: 30678855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of the evolution of steroid specificity in the mineralocorticoid and glucocorticoid receptors.
    Baker ME; Chandsawangbhuwana C; Ollikainen N
    BMC Evol Biol; 2007 Feb; 7():24. PubMed ID: 17306029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.
    Sasagawa S; Shimizu Y; Kami H; Takeuchi T; Mita S; Imada K; Kato S; Mizuguchi K
    Steroids; 2008 Feb; 73(2):222-31. PubMed ID: 18061638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.